The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
In a turbulent market environment, Moderna Inc (BMV:MRNA). shares have touched a 52-week low, sinking to $30.7, with concerning financial metrics showing negative EBITDA of $2.36 billion and gross ...
Utrophin increase in muscle cells after transcriptional adaptation normalises cell function in Duchenne muscular ...
In human cells, only a small proportion of the information written in genes is used to produce proteins. How does the cell select this information? A large molecular machine called the spliceosome ...
Moderna has been ordered to pay almost £44,000 after 12-year-olds were encouraged to join Covid vaccine trials with the ...
Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine ...
In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...
12h
Hosted on MSNLion TCR s Liocyx M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV Related Hepatocellular CarcinomaOn 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...
New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), ...
Scientists have discovered that some tiny segments of RNA thought to be junk instead have a functional role in suppressing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results